Cytokines typical of Th2, Th9, Th17, and Tregs were either low or undetectable, although IL-6, IL-10, and IL-17A levels were higher in peptide-stimulated conditions compared with DMSO control conditions for convalescent COVID-19 participants (Figure 3C). The gene discussed is IL17A; the disease is COVID-19.